Dr. Matthew Corbyons Ercolani, MD

Dr. Ercolani practices at Rapid Care - Adventist Health Physicians Network (W Lacey Blvd) in Hanford, California.

Dr. Ercolani's NPI, 1801059894, was assigned on July 9, 2008. Dr. Ercolani graduated from SUNY Downstate Health Sciences University in 2004. Dr. Ercolani holds Florida license ME107060.

Dr. Ercolani's primary practice is Rapid Care - Adventist Health Physicians Network (W Lacey Blvd), at 1524 W Lacey Blvd, Hanford, CA 93230. The practice phone is (559) 583-4695.

Dr. Ercolani's primary practice is Rapid Care - Adventist Health Physicians Network (W Lacey Blvd) in Hanford, California. Dr. Ercolani is also affiliated with Oroville Hospital. The medical group on file is Adventist Health Physicians Network. Dmand AI also links Dr. Ercolani to 2 more hospitals, 7 medical groups, 3 group practices and clinics, 1 physician office and 1 rural health clinic, each named with a free account. Dr. Ercolani's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ercolani practices, 9 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Ercolani's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Ercolani is board certified in urology by the American Board of Urology. Dmand AI has Dr. Ercolani's licenses on file in 5 states: Florida, Arizona, California, Oregon and New Jersey.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Ercolani treats.

CMS data shows 1,200 Medicare services from Dr. Ercolani across 17 procedure codes in 2024, for 508 Medicare patients. Medicare paid $106,690 for them.

CMS counts 508 Medicare patients who saw Dr. Ercolani in 2024. The largest group is 65 to 74, with 227 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ercolani's median patient age at 71, with 39% women.

In 2024, Dr. Ercolani wrote 463 Medicare Part D claims for 212 patients. 97% of them were for generic drugs. CMS names the drug for 400 of them, across 11 drugs with 11 or more claims each, at $14,602 in total drug cost. In 2023, CMS named 341 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Ercolani for performance year 2024, reported through an alternative payment model (APM). Dr. Ercolani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Ercolani, published from 2011 to 2012. The most frequent topics are Laparoscopy.

CMS Open Payments shows 803 general payments to Dr. Ercolani from 28 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 42% of the total. Ethicon Inc. paid the most, $252,207.

Dmand AI lists 2 awards for Dr. Ercolani, most recently CMS Stage 1 2012 in 2012.

Dr. Ercolani graduated from SUNY Downstate Health Sciences University in 2004. Dr. Ercolani is a member of ACS.

Dr. Ercolani is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.